Reports and Intelligence: Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review - Size, Share, Global Trends 2014 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Reports and Intelligence: Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review - Size, Share, Global Trends 2014

Description:

GlobalData's clinical trial report, “Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2014" provides data on the Chagas Disease (American Trypanosomiasis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chagas Disease (American Trypanosomiasis). Detailed report at: – PowerPoint PPT presentation

Number of Views:37

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Reports and Intelligence: Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review - Size, Share, Global Trends 2014


1

Chagas Disease (American Trypanosomiasis) Global
Clinical Trials Review, H2, 2014

Publisher Global Data
No of pages 63
Publish Date Nov 2014
2
Description


GlobalData's clinical trial report, Chagas
Disease (American Trypanosomiasis) Global
Clinical Trials Review, H2, 2014" provides data
on the Chagas Disease (American Trypanosomiasis)
clinical trial scenario. This report provides
elemental information and data relating to the
clinical trials on Chagas Disease (American
Trypanosomiasis). It includes an overview of the
trial numbers and their recruitment status as per
the site of trial conduction across the globe.
The databook offers a preliminary coverage of
disease clinical trials by their phase, trial
status, prominence of the sponsors and also
provides briefing pertaining to the number of
trials for the key drugs for treating Chagas
Disease (American Trypanosomiasis). This report
is built using data and information sourced from
proprietary databases, primary and secondary
research and in-house analysis by GlobalData's
team of industry experts. Enquire about report
at http//www.reportsandintelligence.com/enquire-
about-report/153549
3
Scope

  • Data on the number of clinical trials conducted
    in North America, South and Central America,
    Europe, Middle-East and Africa and Asia-pacific
    and top five national contributions in each
  • Clinical trial (complete and in progress) data by
    phase, trial status, subjects recruited and
    sponsor type
  • Listings of discontinued trials (suspended,
    withdrawn and terminated)
  • Get all reports of Pharmaceutical category at
    http//www.reportsandintelligence.com/pharmaceutic
    als-market-report

4
Reasons to buy

  • Understand the dynamics of a particular
    indication in a condensed manner
  • Abridged view of the performance of the trials in
    terms of their status, recruitment, location,
    sponsor type and many more
  • Obtain discontinued trial listing for trials
    across the globe
  • Espy the commercial landscape of the major
    Universities / Institutes / Hospitals or
    Companies
  • View detailed report at http//www.reportsandinte
    lligence.com/chagas-disease-american-trypanosomias
    is-global-clinical-trials-review-h2-2014-market

5
Table Of Content


Table of ContentsTable of Contents 2List of
Tables 4List of Figures 5Introduction 6Chagas
Disease (American Trypanosomiasis) 6Report
Guidance 6Clinical Trials by Region 7Clinical
Trials and Average Enrollment by Country 8Top
Countries Contributing to Clinical Trials in
Europe 10Top Countries Contributing to Clinical
Trials in North America 11Top Five Countries
Contributing to Clinical Trials in Central and
South America 12Clinical Trials by G7 Countries
Proportion of Chagas Disease (American
Trypanosomiasis) to Infectious Disease Clinical
Trials 13Clinical Trials by Phase in G7
Countries 14 Clinical Trials in G7 Countries by
Trial Status 15
6
Table Of Content


Clinical Trials by E7 Countries Proportion of
Chagas Disease (American Trypanosomiasis) to
Infectious Disease Clinical Trials 16Clinical
Trials by Phase in E7 Countries 17Clinical
Trials in E7 Countries by Trial Status
18Clinical Trials by Phase 19In Progress Trials
by Phase 20Clinical Trials by Trial Status
21Clinical Trials by End Point Status
22Subjects Recruited Over a Period of Time
23Clinical Trials by Sponsor Type 24Prominent
Sponsors 25Top Companies Participating in Chagas
Disease (American Trypanosomiasis) Therapeutics
Clinical Trials 26Prominent Drugs 27 Clinical
Trial Profiles 28Clinical Trial Overview of Top
Companies 28 Merck Co., Inc. 28
7
Table Of Content


Clinical Trial Overview of Merck Co., Inc.
28Bayer AG 29Clinical Trial Overview of Bayer
AG 29Clinical Trial Overview of Top Institutes /
Government 30Drugs for Neglected Diseases
initiative 30Clinical Trial Overview of Drugs
for Neglected Diseases initiative 30Hospital de
Nios R. Gutierrez de Buenos Aires 31Clinical
Trial Overview of Hospital de Nios R. Gutierrez
de Buenos Aires 31Hospital Sao Rafael
32Clinical Trial Overview of Hospital Sao Rafael
32National Heart, Lung, and Blood Institute
33 Clinical Trial Overview of National Heart,
Lung, and Blood Institute 33Centre de Recerca en
Salut Internacional de Barcelona 34 Get full TOC
at http//www.reportsandintelligence.com/chagas-d
isease-american-trypanosomiasis-global-clinical-tr
ials-review-h2-2014-market/table-of-contents
8

FOR MORE DETAILS
Visit us at
http//www.reportsandintelligence.com/chagas-disea
se-american-trypanosomiasis-global-clinical-trials
-review-h2-2014-market
Stay With Us
TELEPHONE Direct 1 (617) 674-4143 Toll Free
1 (855) 711-1555E-MAIL sales_at_reportsandintellig
ence.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
About PowerShow.com